However, in breast carcinoma cells, FAK signaling also enhances matrix metalloproteinase (Hsia et al., 2003; Wu et al., 2005) and urokinase plasminogen activator expression (Mitra et al., 2006a), which both act in the tumor microenvironment to facilitate matrix degradation and cell invasion. This evidence concerns the gene PTK2 and breast carcinoma.